TY - JOUR
T1 - Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy
AU - Sohn, Elliott H.
AU - Francis, Peter J.
AU - Duncan, Jacque L.
AU - Weleber, Richard G.
AU - Saperstein, David A.
AU - Farrell, Donald F.
AU - Stone, Edwin M.
PY - 2009/7
Y1 - 2009/7
N2 - Objective: To study the phenotypic characteristics of patients with a novel p.E292K mutation in BEST1. Methods: Affected individuals underwent ophthalmic examination and testing that included photography, autofluorescence, optical coherence tomography, and electrophysiological testing. Their DNA was analyzed for BEST1 mutations. Results: Five patients aged 5 to 59 years who expressed the p.E292K mutation in BEST1 were identified in 3 families. Electro-oculographic light-rise was subnormal in all probands and carriers. Carriers had normal findings from fundus examination, multifocal electroretinography, and visual acuity, and were emmetropic or myopic. Only probands had hyperopia and fundus findings typical of Best macular dystrophy. Optical coherence tomography of vitelliform lesions demonstrated retinal pigment epithelium elevation without subretinal fluid; atrophic lesions exhibited disruption of the hyperreflective outer retina-retinal pigment epithelium complex. Intense hyperautofluorescence correlated with the vitelliform lesion. Conclusions: Patients with the Glu292Lys variation in BEST1 exhibit intrafamilial and interfamilial phenotypic variability. A disproportionate fraction (26%) of Best disease-causing mutations occurs in exon 8, suggesting that the portion of protein encoded by this exon (amino acids 290-316) may be especially important to bestrophin's function. Relatively good visual acuity with vitelliform lesions can be explained by preservation of the outer retina, demonstrated by optical coherence tomography. Clinical Relevance: A novel mutation in this region of BEST1 carries implications for disease pathogenesis.
AB - Objective: To study the phenotypic characteristics of patients with a novel p.E292K mutation in BEST1. Methods: Affected individuals underwent ophthalmic examination and testing that included photography, autofluorescence, optical coherence tomography, and electrophysiological testing. Their DNA was analyzed for BEST1 mutations. Results: Five patients aged 5 to 59 years who expressed the p.E292K mutation in BEST1 were identified in 3 families. Electro-oculographic light-rise was subnormal in all probands and carriers. Carriers had normal findings from fundus examination, multifocal electroretinography, and visual acuity, and were emmetropic or myopic. Only probands had hyperopia and fundus findings typical of Best macular dystrophy. Optical coherence tomography of vitelliform lesions demonstrated retinal pigment epithelium elevation without subretinal fluid; atrophic lesions exhibited disruption of the hyperreflective outer retina-retinal pigment epithelium complex. Intense hyperautofluorescence correlated with the vitelliform lesion. Conclusions: Patients with the Glu292Lys variation in BEST1 exhibit intrafamilial and interfamilial phenotypic variability. A disproportionate fraction (26%) of Best disease-causing mutations occurs in exon 8, suggesting that the portion of protein encoded by this exon (amino acids 290-316) may be especially important to bestrophin's function. Relatively good visual acuity with vitelliform lesions can be explained by preservation of the outer retina, demonstrated by optical coherence tomography. Clinical Relevance: A novel mutation in this region of BEST1 carries implications for disease pathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=67650456911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650456911&partnerID=8YFLogxK
U2 - 10.1001/archophthalmol.2009.148
DO - 10.1001/archophthalmol.2009.148
M3 - Article
C2 - 19597114
AN - SCOPUS:67650456911
SN - 0003-9950
VL - 127
SP - 913
EP - 920
JO - Archives of ophthalmology
JF - Archives of ophthalmology
IS - 7
ER -